Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierrick Bourgeat

Showing results (71-80 of 160) with videos related to

Pageof 16
Sort By:
Alzheimer'S & Dementia (Amsterdam, Netherlands)|May 31, 2016
Sensitivity of composite scores to amyloid burden in preclinical Alzheimer's disease: Introducing the Z-scores of Attention, Verbal fluency, and Episodic memory for Nondemented older adults composite scoreYen Ying Lim, Peter J Snyder, Robert H Pietrzak, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 8, 2016
Subjective memory decline predicts greater rates of clinical progression in preclinical Alzheimer's diseaseRachel F Buckley, Paul Maruff, David Ames, et al.
The Lancet. Neurology|July 25, 2016
Clinical and cognitive trajectories in cognitively healthy elderly individuals with suspected non-Alzheimer's disease pathophysiology (SNAP) or Alzheimer's disease pathology: a longitudinal studySamantha C Burnham, Pierrick Bourgeat, Vincent Doré, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|December 8, 2022
Cerebrospinal fluid levels of fatty acid-binding protein 3 are associated with likelihood of amyloidopathy in cognitively healthy individualsKunal Dhiman, Victor L Villemagne, Christopher Fowler, et al.
Journal of Alzheimer'S Disease : JAD|May 28, 2017
Effect of APOE Genotype on Amyloid Deposition, Brain Volume, and Memory in Cognitively Normal Older IndividualsYen Ying Lim, Robert Williamson, Simon M Laws, et al.
The Lancet. Neurology|March 13, 2013
Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort studyVictor L Villemagne, Samantha Burnham, Pierrick Bourgeat, et al.
Brain : a Journal of Neurology|May 26, 2012
Regional dynamics of amyloid-β deposition in healthy elderly, mild cognitive impairment and Alzheimer's disease: a voxelwise PiB-PET longitudinal studyNicolas Villain, Gaël Chételat, Blandine Grassiot, et al.
Neurology|June 17, 2024
Association of Basal Forebrain Atrophy With Cognitive Decline in Early Alzheimer DiseaseYing Xia, Vincent Dore, Jurgen Fripp, et al.
Current Alzheimer Research|October 15, 2013
Pupil response biomarkers for early detection and monitoring of Alzheimer's diseaseShaun Frost, Yogesan Kanagasingam, Hamid Sohrabi, et al.
Journal of Alzheimer'S Disease : JAD|January 27, 2025
Digital detector PET/CT increases Centiloid measures of amyloid in Alzheimer's disease: A head-to-head comparison of camerasAshley Gillman, Pierrick Bourgeat, Timothy Cox, et al.
Pageof 16

Showing results (71-80 of 160) with videos related to

Sort By:
Pageof 16
Alzheimer'S & Dementia (Amsterdam, Netherlands)|May 31, 2016
Sensitivity of composite scores to amyloid burden in preclinical Alzheimer's disease: Introducing the Z-scores of Attention, Verbal fluency, and Episodic memory for Nondemented older adults composite scoreYen Ying Lim, Peter J Snyder, Robert H Pietrzak, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 8, 2016
Subjective memory decline predicts greater rates of clinical progression in preclinical Alzheimer's diseaseRachel F Buckley, Paul Maruff, David Ames, et al.
The Lancet. Neurology|July 25, 2016
Clinical and cognitive trajectories in cognitively healthy elderly individuals with suspected non-Alzheimer's disease pathophysiology (SNAP) or Alzheimer's disease pathology: a longitudinal studySamantha C Burnham, Pierrick Bourgeat, Vincent Doré, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|December 8, 2022
Cerebrospinal fluid levels of fatty acid-binding protein 3 are associated with likelihood of amyloidopathy in cognitively healthy individualsKunal Dhiman, Victor L Villemagne, Christopher Fowler, et al.
Journal of Alzheimer'S Disease : JAD|May 28, 2017
Effect of APOE Genotype on Amyloid Deposition, Brain Volume, and Memory in Cognitively Normal Older IndividualsYen Ying Lim, Robert Williamson, Simon M Laws, et al.
The Lancet. Neurology|March 13, 2013
Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort studyVictor L Villemagne, Samantha Burnham, Pierrick Bourgeat, et al.
Brain : a Journal of Neurology|May 26, 2012
Regional dynamics of amyloid-β deposition in healthy elderly, mild cognitive impairment and Alzheimer's disease: a voxelwise PiB-PET longitudinal studyNicolas Villain, Gaël Chételat, Blandine Grassiot, et al.
Neurology|June 17, 2024
Association of Basal Forebrain Atrophy With Cognitive Decline in Early Alzheimer DiseaseYing Xia, Vincent Dore, Jurgen Fripp, et al.
Current Alzheimer Research|October 15, 2013
Pupil response biomarkers for early detection and monitoring of Alzheimer's diseaseShaun Frost, Yogesan Kanagasingam, Hamid Sohrabi, et al.
Journal of Alzheimer'S Disease : JAD|January 27, 2025
Digital detector PET/CT increases Centiloid measures of amyloid in Alzheimer's disease: A head-to-head comparison of camerasAshley Gillman, Pierrick Bourgeat, Timothy Cox, et al.
Pageof 16